About Transcription factor AP-2 gamma
Transcription factor AP-2 gamma (TFAP2C) is a protein
from Homo sapiens identified by UniProt accession
Q92754, 450 residues long.
MolForge cross-references it against 0 known binders and
119 disease associations.
Target properties
| Protein name | Transcription factor AP-2 gamma |
| UniProt accession | Q92754 |
| Gene | TFAP2C |
| Organism | Homo sapiens |
| Length | 450 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (119)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.53
- FEV/FVC ratio · score 0.35
- blood urea nitrogen measurement · score 0.31
- hair shape measurement · score 0.29
- systolic blood pressure · score 0.28
- smoking status measurement · score 0.28
- glioblastoma multiforme · score 0.27
- snoring measurement · score 0.27
- hair color · score 0.27
- endometrial cancer · score 0.26
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q92754-F1 | alphafold | PREDICTED | 66.28 | — |
Amino-acid sequence (450 residues)
MLWKITDNVK YEEDCEDRHD GSSNGNPRVP HLSSAGQHLY SPAPPLSHTG VAEYQPPPYF PPPYQQLAYS QSADPYSHLG EAYAAAINPL HQPAPTGSQQ QAWPGRQSQE GAGLPSHHGR PAGLLPHLSG LEAGAVSARR DAYRRSDLLL PHAHALDAAG LAENLGLHDM PHQMDEVQNV DDQHLLLHDQ TVIRKGPISM TKNPLNLPCQ KELVGAVMNP TEVFCSVPGR LSLLSSTSKY KVTVAEVQRR LSPPECLNAS LLGGVLRRAK SKNGGRSLRE KLDKIGLNLP AGRRKAAHVT LLTSLVEGEA VHLARDFAYV CEAEFPSKPV AEYLTRPHLG GRNEMAARKN MLLAAQQLCK EFTELLSQDR TPHGTSRLAP VLETNIQNCL SHFSLITHGF GSQAICAAVS ALQNYIKEAL IVIDKSYMNP GDQSPADSNK TLEKMEKHRK
Explore Transcription factor AP-2 gamma with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets